1. Home
  2. ARTL vs SGBX Comparison

ARTL vs SGBX Comparison

Compare ARTL & SGBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTL
  • SGBX
  • Stock Information
  • Founded
  • ARTL 2011
  • SGBX 2007
  • Country
  • ARTL United States
  • SGBX United States
  • Employees
  • ARTL N/A
  • SGBX N/A
  • Industry
  • ARTL Biotechnology: Pharmaceutical Preparations
  • SGBX RETAIL: Building Materials
  • Sector
  • ARTL Health Care
  • SGBX Consumer Discretionary
  • Exchange
  • ARTL Nasdaq
  • SGBX Nasdaq
  • Market Cap
  • ARTL 3.3M
  • SGBX 2.7M
  • IPO Year
  • ARTL N/A
  • SGBX 2017
  • Fundamental
  • Price
  • ARTL $1.02
  • SGBX $0.51
  • Analyst Decision
  • ARTL
  • SGBX
  • Analyst Count
  • ARTL 0
  • SGBX 0
  • Target Price
  • ARTL N/A
  • SGBX N/A
  • AVG Volume (30 Days)
  • ARTL 1.2M
  • SGBX 270.2K
  • Earning Date
  • ARTL 05-16-2025
  • SGBX 05-20-2025
  • Dividend Yield
  • ARTL N/A
  • SGBX N/A
  • EPS Growth
  • ARTL N/A
  • SGBX N/A
  • EPS
  • ARTL N/A
  • SGBX N/A
  • Revenue
  • ARTL N/A
  • SGBX $4,976,618.00
  • Revenue This Year
  • ARTL N/A
  • SGBX $1,628.82
  • Revenue Next Year
  • ARTL N/A
  • SGBX N/A
  • P/E Ratio
  • ARTL N/A
  • SGBX N/A
  • Revenue Growth
  • ARTL N/A
  • SGBX N/A
  • 52 Week Low
  • ARTL $0.82
  • SGBX $0.30
  • 52 Week High
  • ARTL $1.59
  • SGBX $5.90
  • Technical
  • Relative Strength Index (RSI)
  • ARTL 52.13
  • SGBX 60.76
  • Support Level
  • ARTL $0.99
  • SGBX $0.40
  • Resistance Level
  • ARTL $1.05
  • SGBX $0.60
  • Average True Range (ATR)
  • ARTL 0.07
  • SGBX 0.05
  • MACD
  • ARTL 0.00
  • SGBX 0.02
  • Stochastic Oscillator
  • ARTL 30.00
  • SGBX 68.24

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About SGBX Safe & Green Holdings Corp.

Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.

Share on Social Networks: